Posted in | Genetics

Gene therapy analysis - challenges and solutions

The content from our Gene Therapy symposium is now accessible on demand. The symposium showcases a line-up of speakers at the forefront of gene therapy development and vector characterization, highlighting analytical CE-SDS and automated Simple Western technology.

Explore the latest advances in the field, such as:

  • Utilizing automated Simple Western for quantitative AAV characterization
  • Best practices in AAV vector design
  • Determining full-to-empty particle ratios
  • Using iCE Maurice for GMP-grade vector purity assessment

Speakers

Extending the Development of iCEF-Western Method from mAb to AAV to Support Extended Characterization

Gangadhar Dhulipala: Senior Scientist, Regeneron

Landscape of Analytical Methods for the Characterization of AAV Full-to-Empty Particle

Anthony Blaszczyk, PhD: Senior Scientist, USP

Breaking Through the Challenges of rAAV Purity Characterization by CE-SDS

Ana Carreras González, PhD: QC Biochemistry Department Scientist, Viralgen Vector Core Company

Moderator

John Eugenis, PhD: Product Manager Simple Western, Bio-Techne

Other Webinars from Bio-Techne

Medical Webinars by Subject Matter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.